Pacific Edge - Termination of coverage
Edison Investment Research is terminating coverage on Kcell Joint Stock Company (KCEL), Locate Bio, Pacific Edge (PEB), Tungsten Corporation (TUNG)...
514 Views
Pacific Edge - CMS reimbursement obtained
Pacific Edge announced that it has successfully gained inclusion into a local coverage determination (LCD) enabling reimbursement at US$760 per...
296 Views
Pacific Edge - CMS coverage pending
Pacific Edge continues to make progress commercialising its Cxbladder suite of bladder cancer diagnostics products, with three of the four...
1.2k Views
Pacific Edge - Anticipating commercial growth
Pacific Edge continues to make progress commercialising its suite of bladder cancer diagnostics products, with three tests currently available in...
214 Views
A growth year
Pacific Edge continues to make progress in the commercialisation of its bladder cancer diagnostics tests, reporting 35% growth in the number of...
291 Views